1. Home
  2. GNPX vs PW Comparison

GNPX vs PW Comparison

Compare GNPX & PW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • PW
  • Stock Information
  • Founded
  • GNPX 2009
  • PW 1967
  • Country
  • GNPX United States
  • PW United States
  • Employees
  • GNPX N/A
  • PW N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • PW Real Estate Investment Trusts
  • Sector
  • GNPX Health Care
  • PW Real Estate
  • Exchange
  • GNPX Nasdaq
  • PW Nasdaq
  • Market Cap
  • GNPX 6.1M
  • PW 6.4M
  • IPO Year
  • GNPX 2018
  • PW N/A
  • Fundamental
  • Price
  • GNPX $0.75
  • PW $1.18
  • Analyst Decision
  • GNPX Strong Buy
  • PW
  • Analyst Count
  • GNPX 1
  • PW 0
  • Target Price
  • GNPX $10.00
  • PW N/A
  • AVG Volume (30 Days)
  • GNPX 367.1K
  • PW 106.7K
  • Earning Date
  • GNPX 11-13-2024
  • PW 10-31-2024
  • Dividend Yield
  • GNPX N/A
  • PW N/A
  • EPS Growth
  • GNPX N/A
  • PW N/A
  • EPS
  • GNPX N/A
  • PW N/A
  • Revenue
  • GNPX N/A
  • PW $3,153,209.00
  • Revenue This Year
  • GNPX N/A
  • PW N/A
  • Revenue Next Year
  • GNPX N/A
  • PW N/A
  • P/E Ratio
  • GNPX N/A
  • PW N/A
  • Revenue Growth
  • GNPX N/A
  • PW N/A
  • 52 Week Low
  • GNPX $0.28
  • PW $0.40
  • 52 Week High
  • GNPX $13.00
  • PW $2.75
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 40.74
  • PW 44.33
  • Support Level
  • GNPX $0.66
  • PW $1.11
  • Resistance Level
  • GNPX $0.74
  • PW $1.26
  • Average True Range (ATR)
  • GNPX 0.06
  • PW 0.12
  • MACD
  • GNPX 0.00
  • PW -0.02
  • Stochastic Oscillator
  • GNPX 35.04
  • PW 14.00

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About PW Power REIT (MD)

Power REIT is a real estate investment trust (REIT) that owns real estate related to properties for Controlled Environment Agriculture, Renewable Energy and Transportation. The company is actively seeking to expand its real estate portfolio related to Controlled Environment Agriculture for the cultivation of food and cannabis. The company is focused on CEA in the form of a greenhouse which uses dramatically less energy than indoor growing, 95% less water usage than outdoor growing, and does not have any agricultural runoff of fertilizers or pesticides. To date, its greenhouse properties are operated for the cultivation of cannabis by state-licensed operators.

Share on Social Networks: